Delivery Order SPE2DX22D0099-SPE2D826FAC3A
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $903,311.36 to AmerisourceBergen Drug Corp on November 15, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The delivery order is being performed...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $369,718.44 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $134,830.88 to AmerisourceBergen Drug Corp on September 18, 2025, with completion scheduled for September 19, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle running through December 2026. The award was made competitively with no...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $26,354.62 to AmerisourceBergen Drug Corp on November 10, 2025, with completion scheduled for November 12, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was issued with no set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $154,727.82 to AmerisourceBergen Drug Corp on August 18, 2025, with ultimate completion by August 19, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The award was competitively procured without set-aside designation and is being performed at the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,865.12 to AmerisourceBergen Drug Corp on November 8, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $110,265.05 to AmerisourceBergen Drug Corp on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order represents a non-competitive award leveraging AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $62,781.60 to AmerisourceBergen Drug Corp on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order represents a non-competitive award to the pharmaceutical distributor and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,296.85 by the Defense Logistics Agency's Medical Supply Chain on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The award...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,302.51 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The delivery order will be fulfilled from the vendor's...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D826FAC3ADelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $94,752.62 to AmerisourceBergen Drug Corp on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award was made on a competitive basis without set-aside designation, and the work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Through its global pharmaceutical support vehicle, AmerisourceBergen serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning it as a key supplier within the DLA's Pharmaceutical Prime Vendor program, which plans to establish Generation V contracts with multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $94.8k | 11/13/25 |